<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Mesothelioma Journal Articles &#187; Pericardial</title>
	<atom:link href="http://www.mesothelioma-line.com/articles/category/pericardial-mesothelioma/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.mesothelioma-line.com/articles</link>
	<description>Journal Articles on Mesothelioma: Cancer Information for Patients and Families</description>
	<lastBuildDate>Tue, 22 Jun 2010 21:40:25 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
		<item>
		<title>Malignant mesothelioma</title>
		<link>http://www.mesothelioma-line.com/articles/2008/12/23/malignant-mesothelioma-3/</link>
		<comments>http://www.mesothelioma-line.com/articles/2008/12/23/malignant-mesothelioma-3/#comments</comments>
		<pubDate>Tue, 23 Dec 2008 14:46:11 +0000</pubDate>
		<dc:creator>Administrator</dc:creator>
				<category><![CDATA[Benign]]></category>
		<category><![CDATA[CT or CAT scan]]></category>
		<category><![CDATA[Causation]]></category>
		<category><![CDATA[Diagnosis & Differentiation]]></category>
		<category><![CDATA[Environmental Asbestos Exposure]]></category>
		<category><![CDATA[Full Archive]]></category>
		<category><![CDATA[General]]></category>
		<category><![CDATA[Occupational Asbestos Exposure]]></category>
		<category><![CDATA[Pericardial]]></category>
		<category><![CDATA[Peritoneal (Abdominal Mesothelioma)]]></category>
		<category><![CDATA[Pleural]]></category>
		<category><![CDATA[Survival]]></category>
		<category><![CDATA[Symptoms & Symptom Management]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Trimodality Therapy]]></category>
		<category><![CDATA[Tunica Vaginalis Testis]]></category>
		<category><![CDATA[Type of Assessment:]]></category>
		<category><![CDATA[Type of Mesothelioma:]]></category>

		<guid isPermaLink="false">http://www.mesothelioma-line.com/articles/?p=1612</guid>
		<description><![CDATA[Orphanet Journal of Rare Diseases. 2008 Dec 19;3:34. [Link] Moore AJ, Parker RJ, Wiggins J. Department of Respiratory Medicine, Wexham Park Hospital, Wexham, Slough, Berkshire, UK. a.moore@ic.ac.uk Abstract Malignant mesothelioma is a fatal asbestos-associated malignancy originating from the lining cells (mesothelium) of the pleural and peritoneal cavities, as well as the pericardium and the tunica [...]]]></description>
			<content:encoded><![CDATA[<p><em>Orphanet Journal of Rare Diseases</em>. 2008 Dec 19;3:34. [<a href="http://www.ojrd.com/content/3/1/34">Link</a>]</p>
<p><strong>Moore AJ, Parker RJ, Wiggins J.</strong></p>
<p>Department of Respiratory Medicine, Wexham Park Hospital, Wexham, Slough, Berkshire, UK. a.moore@ic.ac.uk</p>
<h3>Abstract</h3>
<p>Malignant mesothelioma is a fatal asbestos-associated malignancy originating from the lining cells (mesothelium) of the pleural and peritoneal cavities, as well as the pericardium and the tunica vaginalis. The exact prevalence is unknown but it is estimated that mesotheliomas represent less than 1% of all cancers. Its incidence is increasing, with an expected peak in the next 10-20 years. Pleural malignant mesothelioma is the most common form of mesothelioma. Typical presenting features are those of chest pain and dyspnoea. Breathlessness due to a pleural effusion without chest pain is reported in about 30% of patients. A chest wall mass, weight loss, sweating, abdominal pain and ascites (due to peritoneal involvement) are less common presentations. Mesothelioma is directly attributable to occupational asbestos exposure with a history of exposure in over 90% of cases. There is also evidence that mesothelioma may result from both para-occupational exposure and non-occupational &#8220;environmental&#8221; exposure. Idiopathic or spontaneous mesothelioma can also occur in the absence of any exposure to asbestos, with a spontaneous rate in humans of around one per million. A combination of accurate exposure history, along with examination radiology and pathology are essential to make the diagnosis. Distinguishing malignant from benign pleural disease can be challenging. The most helpful CT findings suggesting malignant pleural disease are 1) a circumferential pleural rind, 2) nodular pleural thickening, 3) pleural thickening of &gt; 1 cm and 4) mediastinal pleural involvement. Involvement of a multidisciplinary team is recommended to ensure prompt and appropriate management, using a framework of radiotherapy, chemotherapy, surgery and symptom palliation with end of life care. Compensation issues must also be considered. Life expectancy in malignant mesothelioma is poor, with a median survival of about one year following diagnosis.</p>
<h3 class="glossary">Glossary</h3><dl class="glossary"><dt>prevalence</dt><dd> a measure of the proportion of persons in the population with a certain disease at a given time.</dd><dt>diagnosis</dt><dd> identifying a disease by its signs or symptoms, and by using imaging procedures and laboratory findings. The earlier a diagnosis of cancer is made, the better the chance for long-term survival.</dd><dt>chemotherapy</dt><dd><span class="pronunciation">(key-mo-THER-uh-pee)</span> treatment with drugs to destroy cancer cells. Chemotherapy is often used with surgery or radiation to treat cancer when the cancer has spread, when it has come back (recurred), or when there is a strong chance that it could recur.</dd><dt>benign</dt><dd><span class="pronunciation">(be-nine)</span> not cancer; not malignant.</dd><dt>mesothelioma</dt><dd>a tumor derived from mesothelial tissue, such as the peritoneum (lining the abdomen) or pleura (lining the lungs). More on <a href="http://www.mesotheliomacenter.org/">mesothelioma</a>. </dd><dt>tunica vaginalis</dt><dd><div>The serous sheath of the testis and epididymis, derived from the peritoneum; it consists of outer parietal and inner visceral serous layers. </div> </dd><dt>peritoneal</dt><dd><span class="pronunciation">(pair-uh-tuh-nee-al)</span> the serous membrane that lines the cavity of the abdomen. (More on <a href="http://www.mesotheliomacenter.org/about/peritoneal-mesothelioma.php" target="_blank" title="(opens in a new window.)">Peritoneal Mesothelioma</a>.)  </dd><dt>pleural effusion</dt><dd>an abnormal accumulation of fluid, usually caused by trauma or disease, in the pleural space.</dd><dt>ascites</dt><dd><span class="pronunciation">(uh-sigh-tees)</span> excess fluid accumulation in the abdominal (peritoneal) cavity.</dd></dl>]]></content:encoded>
			<wfw:commentRss>http://www.mesothelioma-line.com/articles/2008/12/23/malignant-mesothelioma-3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Localized malignant mesothelioma in the middle mediastinum: Report of a case</title>
		<link>http://www.mesothelioma-line.com/articles/2008/07/10/localized-malignant-mesothelioma-in-the-middle-mediastinum-report-of-a-case/</link>
		<comments>http://www.mesothelioma-line.com/articles/2008/07/10/localized-malignant-mesothelioma-in-the-middle-mediastinum-report-of-a-case/#comments</comments>
		<pubDate>Thu, 10 Jul 2008 14:59:48 +0000</pubDate>
		<dc:creator>Administrator</dc:creator>
				<category><![CDATA[Case Study]]></category>
		<category><![CDATA[Diagnosis & Differentiation]]></category>
		<category><![CDATA[Epithelioid]]></category>
		<category><![CDATA[Full Archive]]></category>
		<category><![CDATA[Pericardial]]></category>
		<category><![CDATA[Type of Assessment:]]></category>

		<guid isPermaLink="false">http://www.mesothelioma-line.com/articles/?p=1259</guid>
		<description><![CDATA[Surgery Today. 2008;38(7):635-8. Epub 2008 Jul 9. [Link] Akamoto S, Ono Y, Ota K, Suzaki N, Sasaki A, Matsuo Y, Hayashi K. Department of Surgery, Jyuzen General Hospital, Ehime, Japan. Abstract Localized malignant mesothelioma in the mediastinum is rare and most known cases have been reported as “localized malignant pericardial mesothelioma.” We report a case [...]]]></description>
			<content:encoded><![CDATA[<p>	<em> Surgery Today.</em> 2008;38(7):635-8. Epub 2008 Jul 9. [<a href="http://www.springerlink.com/content/b437577t23241t73/" target="_blank">Link</a>]</p>
<p><strong>Akamoto S, Ono Y, Ota K, Suzaki N, Sasaki A, Matsuo Y, Hayashi K.</strong></p>
<p>Department of Surgery, Jyuzen General Hospital, Ehime, Japan.</p>
<h3 class="abstract">Abstract </h3>
<p>Localized malignant mesothelioma in the mediastinum is rare and most known cases have been reported as “localized malignant pericardial mesothelioma.” We report a case of a middle mediastinal tumor, which we were able to resect completely. Histopathological examination of the tumor confirmed that it was a malignant epithelial lymphohistiocytoid mesothelioma. We assumed that the tumor was derived from the pericardium. Local recurrence was detected 1 year after resection, and the patient died of the disease about 2 years later.</p>
<p><strong>Keywords</strong>: Localized malignant mesothelioma &#8211; Middle mediastinal tumor &#8211; Lymphohistiocytoid mesothelioma </p>
<h3 class="glossary">Glossary</h3><dl class="glossary"><dt>resection</dt><dd> surgery to remove part or all of an organ or other structure.</dd><dt>recurrence</dt><dd> cancer that has come back after treatment. Local recurrence is when the cancer comes back at the same place as the original cancer. Regional recurrence is when the cancer appears in the lymph nodes near the first site. Distant recurrence is when it appears in organs or tissues (such as the lungs, liver, bone marrow, or brain) farther from the original site than the regional lymph nodes. Metastasis means that the disease has recurred at a distant site.</dd><dt>tumor</dt><dd> an abnormal lump or mass of tissue. Tumors can be benign (not cancerous) or malignant (cancerous).</dd><dt>mesothelioma</dt><dd>a tumor derived from mesothelial tissue, such as the peritoneum (lining the abdomen) or pleura (lining the lungs). More on <a href="http://www.mesotheliomacenter.org/">mesothelioma</a>. </dd></dl>]]></content:encoded>
			<wfw:commentRss>http://www.mesothelioma-line.com/articles/2008/07/10/localized-malignant-mesothelioma-in-the-middle-mediastinum-report-of-a-case/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pulmonary Paragonimiasis with Coincidental Malignant Mesothelioma</title>
		<link>http://www.mesothelioma-line.com/articles/2008/06/04/pulmonary-paragonimiasis-with-coincidental-malignant-mesothelioma/</link>
		<comments>http://www.mesothelioma-line.com/articles/2008/06/04/pulmonary-paragonimiasis-with-coincidental-malignant-mesothelioma/#comments</comments>
		<pubDate>Wed, 04 Jun 2008 15:28:12 +0000</pubDate>
		<dc:creator>Administrator</dc:creator>
				<category><![CDATA[Case Study]]></category>
		<category><![CDATA[Diagnosis & Differentiation]]></category>
		<category><![CDATA[Full Archive]]></category>
		<category><![CDATA[Pericardial]]></category>
		<category><![CDATA[Pleural]]></category>
		<category><![CDATA[Sarcomatoid]]></category>
		<category><![CDATA[Type of Assessment:]]></category>
		<category><![CDATA[Type of Mesothelioma:]]></category>

		<guid isPermaLink="false">http://www.mesothelioma-line.com/articles/?p=1206</guid>
		<description><![CDATA[Internal Medicine. 2008;47(11):1027-31. Epub 2008 Jun 2. [Link] Yamazaki M, Ohwada A, Miyaji A, Yamazaki H, Nara T, Hirai S, Fujii H, Uekusa T, Suzuki M, Iwase A, Takahashi K. Department of Respiratory Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo. mariko@med.juntendo.ac.jp Abstract A 72-year-old man patient was referred to our institution for evaluation and [...]]]></description>
			<content:encoded><![CDATA[<p><em>Internal Medicine</em>. 2008;47(11):1027-31. Epub 2008 Jun 2. [<a href="http://www.jstage.jst.go.jp/article/internalmedicine/47/11/47_1027/_article" target="_blank">Link</a>]</p>
<p><strong>Yamazaki M, Ohwada A, Miyaji A, Yamazaki H, Nara T, Hirai S, Fujii H, Uekusa T, Suzuki M, Iwase A, Takahashi K.</strong></p>
<p>Department of Respiratory Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo. mariko@med.juntendo.ac.jp</p>
<h3>Abstract </h3>
<p>A 72-year-old man patient was referred to our institution for evaluation and treatment of right pleural effusion. Eosinophilic pleural effusion and peripheral eosinophilia were identified during the course of hospitalization. Pulmonary paragonimiasis was confirmed by the presence of paragonimus-specific IgG antibodies for <em>Paragonimus (P.) westermani</em> and <em>P. miyazakii</em> in his serum. Although Praziquantel, a highly effective agent for the treatment of lung flukes was repeatedly administered, the pleural effusion did not subside and the patient&#8217;s condition gradually deteriorated until his death due to circulatory insufficiency. Postmortem examination revealed malignant mesothelioma of the sarcomatous type encasing the right lung and heart. Cardiac involvement accompanied with old and recent-onset myocardial ischemic changes resulted in death of this patient. Here, we report a very rare case of malignant mesothelioma with a concomitant infection of parasitic lung fluke.</p>
<p><strong>Keywords</strong>:	paragonimiasis, malignant mesothelioma, eosinophilia</p>
<h3 class="glossary">Glossary</h3><dl class="glossary"><dt>mesothelioma</dt><dd>a tumor derived from mesothelial tissue, such as the peritoneum (lining the abdomen) or pleura (lining the lungs). More on <a href="http://www.mesotheliomacenter.org/">mesothelioma</a>. </dd><dt>pleural effusion</dt><dd>an abnormal accumulation of fluid, usually caused by trauma or disease, in the pleural space.</dd></dl>]]></content:encoded>
			<wfw:commentRss>http://www.mesothelioma-line.com/articles/2008/06/04/pulmonary-paragonimiasis-with-coincidental-malignant-mesothelioma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Activity of the Campania Register of Mesothelioma from july 2003 to October 2007</title>
		<link>http://www.mesothelioma-line.com/articles/2008/04/16/activity-of-the-campania-register-of-mesothelioma-from-july-2003-to-october-2007/</link>
		<comments>http://www.mesothelioma-line.com/articles/2008/04/16/activity-of-the-campania-register-of-mesothelioma-from-july-2003-to-october-2007/#comments</comments>
		<pubDate>Wed, 16 Apr 2008 16:00:17 +0000</pubDate>
		<dc:creator>Administrator</dc:creator>
				<category><![CDATA[Causation]]></category>
		<category><![CDATA[Epidemiological]]></category>
		<category><![CDATA[Full Archive]]></category>
		<category><![CDATA[General]]></category>
		<category><![CDATA[Occupational Asbestos Exposure]]></category>
		<category><![CDATA[Pericardial]]></category>
		<category><![CDATA[Peritoneal (Abdominal Mesothelioma)]]></category>
		<category><![CDATA[Pleural]]></category>
		<category><![CDATA[Tunica Vaginalis Testis]]></category>
		<category><![CDATA[Type of Assessment:]]></category>
		<category><![CDATA[Type of Mesothelioma:]]></category>

		<guid isPermaLink="false">http://www.mesothelioma-line.com/articles/?p=1133</guid>
		<description><![CDATA[Giornale Italiano di Medicina del Lavoro ed Ergonomia. 2007 Jul-Sep;29(3 Suppl):642-4. [Link] Menegozzo M, Izzo F, Canfora ML, Petronzio MF, Menegozzo S. Registro Mesoteliomi della Campania, Dipartimento di Medicina Sperimentale, Seconda Università degli Studi di Napoli. Abstract Campania Mesothelioma Register was established in 2002; its purpose is to record every case of malignant mesothelioma that [...]]]></description>
			<content:encoded><![CDATA[<p> <em>Giornale Italiano di Medicina del Lavoro ed Ergonomia. </em>2007 Jul-Sep;29(3 Suppl):642-4. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/18409885?dopt=AbstractPlus" target="_blank">Link</a>]</p>
<p><strong>Menegozzo M, Izzo F, Canfora ML, Petronzio MF, Menegozzo S.</strong></p>
<p>Registro Mesoteliomi della Campania, Dipartimento di Medicina Sperimentale, Seconda Università degli Studi di Napoli.</p>
<h3 class="abstract">Abstract </h3>
<p>Campania Mesothelioma Register was established in 2002; its purpose is to record every case of malignant mesothelioma that occurs in the registered population of Campania. Its aim is to identify new dangerous asbestos sources, by giving patients a questionnaire about their working and living habits. The questionnaire used is by National Mesothelioma Register (ReNaM). Analyzing carefully the answers to the questionnaire, it is possible to classify patients&#8217; exposure with a code given by ReNaM. By means of a recognition identification network, COR Campania identified 492 cases of malignant mesothelioma (pleura, pericardium, peritoneum and tunica vaginalis of the testis) diagnosed between 1996-2007. The analysis of the ReNaM questionnaire confirms a prevalence of professional exposures (71%), however unknown exposures (15%) also play an important role. The economic sector that determined the greatest number of professional exposures are Construction (17.5%), Industrial Metalwork (13.13%), Railway Car (9.3%), Vehicle production and maintenance (8.16%), Ship building (7.5%).</p>
<h3 class="glossary">Glossary</h3><dl class="glossary"><dt>prevalence</dt><dd> a measure of the proportion of persons in the population with a certain disease at a given time.</dd><dt>pleura</dt><dd><span class="pronunciation">(pler-uh)</span> the membrane around the lungs and lining of the chest cavity. (<a href="http://www.mesotheliomacenter.org/about/pleural-mesothelioma.php" target="_blank" title="(opens in a new window.)">Pleural mesothelioma</a>.)  </dd><dt>mesothelioma</dt><dd>a tumor derived from mesothelial tissue, such as the peritoneum (lining the abdomen) or pleura (lining the lungs). More on <a href="http://www.mesotheliomacenter.org/">mesothelioma</a>. </dd><dt>tunica vaginalis</dt><dd><div>The serous sheath of the testis and epididymis, derived from the peritoneum; it consists of outer parietal and inner visceral serous layers. </div> </dd></dl>]]></content:encoded>
			<wfw:commentRss>http://www.mesothelioma-line.com/articles/2008/04/16/activity-of-the-campania-register-of-mesothelioma-from-july-2003-to-october-2007/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pericardial malignant mesothelioma: a latent complication of radiotherapy?</title>
		<link>http://www.mesothelioma-line.com/articles/2008/02/19/pericardial-malignant-mesothelioma-a-latent-complication-of-radiotherapy/</link>
		<comments>http://www.mesothelioma-line.com/articles/2008/02/19/pericardial-malignant-mesothelioma-a-latent-complication-of-radiotherapy/#comments</comments>
		<pubDate>Tue, 19 Feb 2008 20:40:39 +0000</pubDate>
		<dc:creator>Administrator</dc:creator>
				<category><![CDATA[Carboplatin]]></category>
		<category><![CDATA[Case Study]]></category>
		<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[Diagnosis & Differentiation]]></category>
		<category><![CDATA[Full Archive]]></category>
		<category><![CDATA[Pemetrexed (Alimta)]]></category>
		<category><![CDATA[Pericardial]]></category>
		<category><![CDATA[Radiation]]></category>
		<category><![CDATA[Survival]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Type of Assessment:]]></category>
		<category><![CDATA[Type of Mesothelioma:]]></category>

		<guid isPermaLink="false">http://www.mesothelioma-line.com/articles/2008/02/19/pericardial-malignant-mesothelioma-a-latent-complication-of-radiotherapy/</guid>
		<description><![CDATA[European Journal of Cardiothoracic Surgery. 2008 Feb 13 [Epub ahead of print] [Link] Small GR, Nicolson M, Buchan K, Broadhurst P. Department of Cardiology, University of Aberdeen, Aberdeen, Scotland AB25 2ZN, United Kingdom. Abstract Pericardial diseases can be difficult to differentiate from myocardial conditions. Diagnosis can be challenging and often requires the use of different [...]]]></description>
			<content:encoded><![CDATA[<p><em>European Journal of Cardiothoracic Surgery</em>. 2008 Feb 13 [Epub ahead of print] [<a href="http://www.sciencedirect.com/science?_ob=ArticleURL&#038;_udi=B6T35-4RV1JRJ-1&#038;_user=10&#038;_rdoc=1&#038;_fmt=&#038;_orig=search&#038;_sort=d&#038;view=c&#038;_acct=C000050221&#038;_version=1&#038;_urlVersion=0&#038;_userid=10&#038;md5=659bb1177af13f1df5f7978dceb57d9c" target="_blank">Link</a>]</p>
<p><strong> Small GR, Nicolson M, Buchan K, Broadhurst P.</strong></p>
<p>Department of Cardiology, University of Aberdeen, Aberdeen, Scotland AB25 2ZN, United Kingdom.</p>
<h3>Abstract</h3>
<p>Pericardial diseases can be difficult to differentiate from myocardial conditions. Diagnosis can be challenging and often requires the use of different imaging modalities. Here, we describe a case which presented with common cardiac symptoms which were shown to be the result of a rare condition. A 62-year-old lady presented with left femoral artery embolism. Post-embolectomy she developed cardiac failure. Three months previously an acellular, sterile pericardial effusion had been drained. In 1993 a left mastectomy and axillary node clearance was performed for breast cancer. Adjuvant chemotherapy and radiotherapy were administered. Examination revealed a raised jugular venous pressure (JVP) with rapid Y descent and Kussmaul&#8217;s sign. CT chest and abdomen found no recurrence of breast carcinoma. Cardiac MRI demonstrated thickened pericardium. At cardiac catheterisation haemodynamic responses consistent with constrictive pericarditis were seen. Pericardectomy was performed. Histology revealed pericardial epithelioid malignant mesothelioma. 18-FDG-PET CT post-operatively was negative in the pericardium and pleura. Chemotherapy with pemetrexed and carboplatin was given. The patient died 9 months after presentation. Radiotherapy and asbestos exposure are both associated with pericardial mesothelioma and the aetiology in this case was not clear. The condition carries a poor prognosis and is invariable fatal although newer chemotherapeutic regimens have prolonged survival times.</p>
<p><strong>Keywords:</strong> Pericardium; Mesothelioma; Radiotherapy </p>
<h3 class="glossary">Glossary</h3><dl class="glossary"><dt>recurrence</dt><dd> cancer that has come back after treatment. Local recurrence is when the cancer comes back at the same place as the original cancer. Regional recurrence is when the cancer appears in the lymph nodes near the first site. Distant recurrence is when it appears in organs or tissues (such as the lungs, liver, bone marrow, or brain) farther from the original site than the regional lymph nodes. Metastasis means that the disease has recurred at a distant site.</dd><dt>prognosis</dt><dd><span class="pronunciation">(prog-no-sis)</span> a prediction of the course of disease; the outlook for the cure of the patient. For example, women with breast cancer that was detected early and who received prompt treatment have a good prognosis.</dd><dt>pleura</dt><dd><span class="pronunciation">(pler-uh)</span> the membrane around the lungs and lining of the chest cavity. (<a href="http://www.mesotheliomacenter.org/about/pleural-mesothelioma.php" target="_blank" title="(opens in a new window.)">Pleural mesothelioma</a>.)  </dd><dt>MRI</dt><dd> Stands for magnetic resonance imaging. A method of taking pictures of the inside of the body. Instead of using x-rays, MRI uses a powerful magnet and transmits radio waves through the body; the images appear on a computer screen as well as on film. Like x-rays, the procedure is physically painless, but some people find it psychologically uncomfortable to be in the small core of the MRI machine.</dd><dt>imaging</dt><dd> any method used to produce a picture of internal body structures. Some imaging methods used to detect cancer are x-rays (including mammograms and CT scans), magnetic resonance imaging (MRI), scintigraphy, and ultrasound.</dd><dt>diagnosis</dt><dd> identifying a disease by its signs or symptoms, and by using imaging procedures and laboratory findings. The earlier a diagnosis of cancer is made, the better the chance for long-term survival.</dd><dt>chemotherapy</dt><dd><span class="pronunciation">(key-mo-THER-uh-pee)</span> treatment with drugs to destroy cancer cells. Chemotherapy is often used with surgery or radiation to treat cancer when the cancer has spread, when it has come back (recurred), or when there is a strong chance that it could recur.</dd><dt>carcinoma</dt><dd><span class="pronunciation">(car-sin-o-ma)</span> a malignant tumor that begins in the lining layer (epithelial cells) of organs. At least 80% of all cancers are carcinomas.</dd><dt>cancer</dt><dd>malignancy; a group of diseases typified by abnormal, generally out-of-control, cell growth.</dd><dt>mesothelioma</dt><dd>a tumor derived from mesothelial tissue, such as the peritoneum (lining the abdomen) or pleura (lining the lungs). More on <a href="http://www.mesotheliomacenter.org/">mesothelioma</a>. </dd><dt>pemetrexed</dt><dd>chemotheraputic agent that interferes with a crucial process that allows cancer cells to reproduce and spread. Specifically, pemetrexed stops the production of three enzymes that are required to feed the cancer cell. Often used in combination with cisplatin. Marketed under the name ALIMTA. See: <a href="/articles/glossary/?id=5">Alimta</a>. </dd></dl>]]></content:encoded>
			<wfw:commentRss>http://www.mesothelioma-line.com/articles/2008/02/19/pericardial-malignant-mesothelioma-a-latent-complication-of-radiotherapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Primary pericardial mesothelioma</title>
		<link>http://www.mesothelioma-line.com/articles/2007/10/16/primary-pericardial-mesothelioma/</link>
		<comments>http://www.mesothelioma-line.com/articles/2007/10/16/primary-pericardial-mesothelioma/#comments</comments>
		<pubDate>Tue, 16 Oct 2007 14:40:43 +0000</pubDate>
		<dc:creator>Administrator</dc:creator>
				<category><![CDATA[Carboplatin]]></category>
		<category><![CDATA[Case Study]]></category>
		<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[Full Archive]]></category>
		<category><![CDATA[Pemetrexed (Alimta)]]></category>
		<category><![CDATA[Pericardial]]></category>
		<category><![CDATA[Radiation]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Type of Assessment:]]></category>
		<category><![CDATA[Type of Mesothelioma:]]></category>

		<guid isPermaLink="false">http://www.mesothelioma-line.com/articles/2007/10/16/primary-pericardial-mesothelioma/</guid>
		<description><![CDATA[Lung Cancer. 2007 Oct 11; [Epub ahead of print] [Link] Santos C, Montesinos J, Casta&#241;er E, Sole JM, Baga R. Hospital de Sabadell, Corporaci&#243; Parc Taul&#237;, Institut Universitari, Sabadell-Barcelona, Spain. Abstract Primary pericardial mesothelioma is a rare clinical entity; about 150 cases have been described in literature. It is a highly aggressive tumour with global [...]]]></description>
			<content:encoded><![CDATA[<p><em>Lung Cancer</em>. 2007 Oct 11; [Epub ahead of print] [<a href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&#038;cmd=Retrieve&#038;dopt=AbstractPlus&#038;list_uids=17936406&#038;itool=iconabstr&#038;itool=pubmed_DocSum" target="_blank">Link</a>]</p>
<p><strong>Santos C, Montesinos J, Casta&#241;er E, Sole JM, Baga R.</strong></p>
<p>Hospital de Sabadell, Corporaci&#243; Parc Taul&#237;, Institut Universitari, Sabadell-Barcelona, Spain.</p>
<h3 class="abstract">Abstract</h3>
<p>Primary pericardial mesothelioma is a rare clinical entity; about 150 cases have been described in literature. It is a highly aggressive tumour with global survival under 6 months. We present a 44-year-old man with a primary pericardial mesothelioma who received treatment under clinical essay with carboplatinum and pemetrexed reaching tumoral response; consolidation radiotherapy was administered. Ten months after end of radiotherapy, tumoral progression was detected, and patient received second line of chemotherapy. The patient died 16 months after diagnosis. New cytotoxic drugs can improve the prognosis of this rare entity.</p>
<h3 class="glossary">Glossary</h3><dl class="glossary"><dt>prognosis</dt><dd><span class="pronunciation">(prog-no-sis)</span> a prediction of the course of disease; the outlook for the cure of the patient. For example, women with breast cancer that was detected early and who received prompt treatment have a good prognosis.</dd><dt>diagnosis</dt><dd> identifying a disease by its signs or symptoms, and by using imaging procedures and laboratory findings. The earlier a diagnosis of cancer is made, the better the chance for long-term survival.</dd><dt>cytotoxic</dt><dd><span class="pronunciation">(site-o-tox-ik)</span> toxic to cells; cell-killing.</dd><dt>chemotherapy</dt><dd><span class="pronunciation">(key-mo-THER-uh-pee)</span> treatment with drugs to destroy cancer cells. Chemotherapy is often used with surgery or radiation to treat cancer when the cancer has spread, when it has come back (recurred), or when there is a strong chance that it could recur.</dd><dt>cancer</dt><dd>malignancy; a group of diseases typified by abnormal, generally out-of-control, cell growth.</dd><dt>mesothelioma</dt><dd>a tumor derived from mesothelial tissue, such as the peritoneum (lining the abdomen) or pleura (lining the lungs). More on <a href="http://www.mesotheliomacenter.org/">mesothelioma</a>. </dd><dt>pemetrexed</dt><dd>chemotheraputic agent that interferes with a crucial process that allows cancer cells to reproduce and spread. Specifically, pemetrexed stops the production of three enzymes that are required to feed the cancer cell. Often used in combination with cisplatin. Marketed under the name ALIMTA. See: <a href="/articles/glossary/?id=5">Alimta</a>. </dd></dl>]]></content:encoded>
			<wfw:commentRss>http://www.mesothelioma-line.com/articles/2007/10/16/primary-pericardial-mesothelioma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Malignant mediastinal tumor with bone formation&#8211;mesothelioma or sarcoma?</title>
		<link>http://www.mesothelioma-line.com/articles/2007/10/03/malignant-mediastinal-tumor-with-bone-formation-mesothelioma-or-sarcoma/</link>
		<comments>http://www.mesothelioma-line.com/articles/2007/10/03/malignant-mediastinal-tumor-with-bone-formation-mesothelioma-or-sarcoma/#comments</comments>
		<pubDate>Wed, 03 Oct 2007 16:10:22 +0000</pubDate>
		<dc:creator>Administrator</dc:creator>
				<category><![CDATA[Carboplatin]]></category>
		<category><![CDATA[Case Study]]></category>
		<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[Diagnosis & Differentiation]]></category>
		<category><![CDATA[Full Archive]]></category>
		<category><![CDATA[Pemetrexed (Alimta)]]></category>
		<category><![CDATA[Pericardial]]></category>
		<category><![CDATA[Pleural]]></category>
		<category><![CDATA[Sarcomatoid]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Tumor Debulking]]></category>
		<category><![CDATA[Type of Assessment:]]></category>
		<category><![CDATA[Type of Mesothelioma:]]></category>

		<guid isPermaLink="false">http://www.mesothelioma-line.com/articles/2007/10/03/malignant-mediastinal-tumor-with-bone-formation-mesothelioma-or-sarcoma/</guid>
		<description><![CDATA[Journal of Thoracic Oncology. 2007 Oct;2(10):983-4 [Link] Hillerdal G, Elmberger G. Department of Lung Medicine, Karolinska University Hospital, Stockholm, Sweden. gunnar.hillerdal@karolinska.se Abstract Mesothelioma can occur in different variants, some of which are difficult or impossible to differentiate from sarcomas. There are scattered reports of sarcomatous mesotheliomas that have osteogenic properties. Here, we report a 57-year [...]]]></description>
			<content:encoded><![CDATA[<p><em>Journal of Thoracic Oncology</em>. 2007 Oct;2(10):983-4 [<a href="http://www.jto.org/pt/re/jto/abstract.01243894-200710000-00019.htm;jsessionid=HKwLg4vCzDJ8GfcRLSpQskhJcp0bQzxkXJd4FQlpjW2h0rfYhGKK!65375592!181195628!8091!-1" target="_blank">Link</a>]</p>
<p><strong>Hillerdal G</strong>, <strong>Elmberger G</strong>.</p>
<p>Department of Lung Medicine, Karolinska University Hospital, Stockholm, Sweden. gunnar.hillerdal@karolinska.se</p>
<h3 class="abstract">Abstract</h3>
<p>Mesothelioma can occur in different variants, some of which are difficult or impossible to differentiate from sarcomas. There are scattered reports of sarcomatous mesotheliomas that have osteogenic properties. Here, we report a 57-year old man who presented with a mediastinal tumor containing scattered irregular calcifications with some scattered pleural thickening of the right pleura. Biopsy showed a sarcoma with bone formation. The man was born in the Turkish village of Karain, where the incidence of mesothelioma is extremely high, and a sarcomatous mesothelioma was therefore diagnosed. Since the tumor was pressing against the large vessels and heart, a debulking was performed, followed by Pemetrexed and Carboplatin treatment. However, the tumor grew rapidly and spread to the pleura, involved the heart, and the patient succumbed. This is to our knowledge the first report of a sarcomatous mesothelioma with bone formation from environmental exposure to mineral fibers.</p>
<h3 class="glossary">Glossary</h3><dl class="glossary"><dt>sarcoma</dt><dd><span class="pronunciation">(sar-co-muh)</span> a malignant tumor growing from connective tissues, such as cartilage, fat, muscle, or bone.</dd><dt>pleura</dt><dd><span class="pronunciation">(pler-uh)</span> the membrane around the lungs and lining of the chest cavity. (<a href="http://www.mesotheliomacenter.org/about/pleural-mesothelioma.php" target="_blank" title="(opens in a new window.)">Pleural mesothelioma</a>.)  </dd><dt>oncology</dt><dd><span class="pronunciation">(on-call-o-jee)</span> the branch of medicine concerned with the diagnosis and treatment of cancer.</dd><dt>biopsy</dt><dd><span class="pronunciation">(buy-op-see)</span> the removal of a sample of tissue to see whether cancer cells are present. There are several kinds of biopsies. In some, a very thin needle is used to draw fluid and cells from a lump. In a core biopsy, a larger needle is used to remove more tissue.</dd><dt>tumor</dt><dd> an abnormal lump or mass of tissue. Tumors can be benign (not cancerous) or malignant (cancerous).</dd><dt>mesothelioma</dt><dd>a tumor derived from mesothelial tissue, such as the peritoneum (lining the abdomen) or pleura (lining the lungs). More on <a href="http://www.mesotheliomacenter.org/">mesothelioma</a>. </dd><dt>pemetrexed</dt><dd>chemotheraputic agent that interferes with a crucial process that allows cancer cells to reproduce and spread. Specifically, pemetrexed stops the production of three enzymes that are required to feed the cancer cell. Often used in combination with cisplatin. Marketed under the name ALIMTA. See: <a href="/articles/glossary/?id=5">Alimta</a>. </dd></dl>]]></content:encoded>
			<wfw:commentRss>http://www.mesothelioma-line.com/articles/2007/10/03/malignant-mediastinal-tumor-with-bone-formation-mesothelioma-or-sarcoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Report of a Case of Pericardial Mesothelioma with Liver Metastases Responding Well to Pemetrexed and Platinum-Based Chemotherapy</title>
		<link>http://www.mesothelioma-line.com/articles/2007/09/01/report-of-a-case-of-pericardial-mesothelioma-with-liver-metastases-responding-well-to-pemetrexed-and-platinum-based-chemotherapy/</link>
		<comments>http://www.mesothelioma-line.com/articles/2007/09/01/report-of-a-case-of-pericardial-mesothelioma-with-liver-metastases-responding-well-to-pemetrexed-and-platinum-based-chemotherapy/#comments</comments>
		<pubDate>Sat, 01 Sep 2007 19:27:28 +0000</pubDate>
		<dc:creator>Administrator</dc:creator>
				<category><![CDATA[Carboplatin]]></category>
		<category><![CDATA[Case Study]]></category>
		<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[Determining Efficacy]]></category>
		<category><![CDATA[Full Archive]]></category>
		<category><![CDATA[Pemetrexed (Alimta)]]></category>
		<category><![CDATA[Pericardial]]></category>
		<category><![CDATA[Survival]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Type of Assessment:]]></category>
		<category><![CDATA[Type of Mesothelioma:]]></category>

		<guid isPermaLink="false">http://www.mesothelioma-line.com/articles/2007/09/01/report-of-a-case-of-pericardial-mesothelioma-with-liver-metastases-responding-well-to-pemetrexed-and-platinum-based-chemotherapy/</guid>
		<description><![CDATA[Journal of Thoracic Oncology. 2007 Aug;2(8):780-1. [Link] Doval DC, Pande SB, Sharma JB, Rao SA, Prakash N, Vaid AK. Department of Medical Oncology, Rajiv Gandhi Cancer Institute, New Delhi, India. dcdoval@yahoo.com Abstract Pericardial mesothelioma remains a disease with a bleak prognosis. We report the case of a patient with metastases to liver and good response [...]]]></description>
			<content:encoded><![CDATA[<p><em>Journal of Thoracic Oncology</em>. 2007 Aug;2(8):780-1. [<a href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=17762349&amp;itool=iconabstr&amp;itool=pubmed_DocSum" target="_blank">Link</a>]</p>
<p><strong>Doval DC, Pande SB, Sharma JB, Rao SA, Prakash N, Vaid AK.</strong></p>
<p>Department of Medical Oncology, Rajiv Gandhi Cancer Institute, New Delhi, India. dcdoval@yahoo.com</p>
<h3 class="abstract">Abstract</h3>
<p>Pericardial mesothelioma remains a disease with a bleak prognosis. We report the case of a patient with metastases to liver and good response to pemetrexed and carboplatin-based combination chemotherapy and consequent prolonged progression-free survival.</p>
<h3 class="glossary">Glossary</h3><dl class="glossary"><dt>prognosis</dt><dd><span class="pronunciation">(prog-no-sis)</span> a prediction of the course of disease; the outlook for the cure of the patient. For example, women with breast cancer that was detected early and who received prompt treatment have a good prognosis.</dd><dt>oncology</dt><dd><span class="pronunciation">(on-call-o-jee)</span> the branch of medicine concerned with the diagnosis and treatment of cancer.</dd><dt>chemotherapy</dt><dd><span class="pronunciation">(key-mo-THER-uh-pee)</span> treatment with drugs to destroy cancer cells. Chemotherapy is often used with surgery or radiation to treat cancer when the cancer has spread, when it has come back (recurred), or when there is a strong chance that it could recur.</dd><dt>cancer</dt><dd>malignancy; a group of diseases typified by abnormal, generally out-of-control, cell growth.</dd><dt>mesothelioma</dt><dd>a tumor derived from mesothelial tissue, such as the peritoneum (lining the abdomen) or pleura (lining the lungs). More on <a href="http://www.mesotheliomacenter.org/">mesothelioma</a>. </dd><dt>pemetrexed</dt><dd>chemotheraputic agent that interferes with a crucial process that allows cancer cells to reproduce and spread. Specifically, pemetrexed stops the production of three enzymes that are required to feed the cancer cell. Often used in combination with cisplatin. Marketed under the name ALIMTA. See: <a href="/articles/glossary/?id=5">Alimta</a>. </dd></dl>]]></content:encoded>
			<wfw:commentRss>http://www.mesothelioma-line.com/articles/2007/09/01/report-of-a-case-of-pericardial-mesothelioma-with-liver-metastases-responding-well-to-pemetrexed-and-platinum-based-chemotherapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Disseminated Intravascular Coagulopathy Caused by Intracardiac Mesothelioma</title>
		<link>http://www.mesothelioma-line.com/articles/2006/11/30/disseminated-intravascular-coagulopathy-caused-by-intracardiac-mesothelioma/</link>
		<comments>http://www.mesothelioma-line.com/articles/2006/11/30/disseminated-intravascular-coagulopathy-caused-by-intracardiac-mesothelioma/#comments</comments>
		<pubDate>Thu, 30 Nov 2006 22:03:15 +0000</pubDate>
		<dc:creator>Administrator</dc:creator>
				<category><![CDATA[Case Study]]></category>
		<category><![CDATA[Full Archive]]></category>
		<category><![CDATA[Pericardial]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Type of Assessment:]]></category>
		<category><![CDATA[Type of Mesothelioma:]]></category>

		<guid isPermaLink="false">http://www.mesothelioma-line.com/articles/2007/11/30/disseminated-intravascular-coagulopathy-caused-by-intracardiac-mesothelioma/</guid>
		<description><![CDATA[Asian Cardiovascular &#38; Thoracic Annals.. 2006 Dec;14(6):517-9. [Link] Tao Jin, MD, Hai-Yong Wang, MD1, Yi-Ming Ni, MD Department of Cardiothoracic Surgery 1 Department of Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China For reprint information contact: Yiming Ni, MD Tel/fax: 86 571 8723 6645 Email: Ni_yiming@hotmail.com, Department of Cardiothoracic Surgery, The [...]]]></description>
			<content:encoded><![CDATA[<p><em>Asian Cardiovascular &amp; Thoracic Annals.</em>. 2006 Dec;14(6):517-9. [<a href="http://asianannals.ctsnetjournals.org/cgi/content/abstract/14/6/517" target="_blank">Link</a>]</p>
<p> <strong> <nobr>Tao Jin, MD</nobr>, <nobr>Hai-Yong Wang, MD<sup>1</sup></nobr>, <nobr>Yi-Ming Ni, MD</nobr> </strong></p>
<p>Department of Cardiothoracic Surgery<br />
  <sup>1</sup> Department of Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China </p>
<p> For reprint information contact: Yiming <u>Ni</u>, MD Tel/fax: 86 571 8723 6645 Email: <a href="mailto:Ni_yiming@hotmail.com">Ni_yiming@hotmail.com</a>, Department of Cardiothoracic Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, Zhejiang 310003, China. </font></p>
<h3 class="abstract">Abstract</h3>
<p>We report a case of intracardiac mesothelioma complicated by chronic disseminated intravascular coagulopathy in a 50-year-old woman. Her symptoms were completely relieved by emergency resection of the tumor. Primary resection of the intracardiac mesothelioma is adequate treatment for this complicated surgical problem.</p>
<h3 class="glossary">Glossary</h3><dl class="glossary"><dt>resection</dt><dd> surgery to remove part or all of an organ or other structure.</dd><dt>oncology</dt><dd><span class="pronunciation">(on-call-o-jee)</span> the branch of medicine concerned with the diagnosis and treatment of cancer.</dd><dt>tumor</dt><dd> an abnormal lump or mass of tissue. Tumors can be benign (not cancerous) or malignant (cancerous).</dd><dt>mesothelioma</dt><dd>a tumor derived from mesothelial tissue, such as the peritoneum (lining the abdomen) or pleura (lining the lungs). More on <a href="http://www.mesotheliomacenter.org/">mesothelioma</a>. </dd></dl>]]></content:encoded>
			<wfw:commentRss>http://www.mesothelioma-line.com/articles/2006/11/30/disseminated-intravascular-coagulopathy-caused-by-intracardiac-mesothelioma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sarcomatous pleural mesothelioma metastatic to left ventricular endocardium</title>
		<link>http://www.mesothelioma-line.com/articles/2006/10/07/sarcomatous-pleural-mesothelioma-metastatic-to-left-ventricular-endocardium/</link>
		<comments>http://www.mesothelioma-line.com/articles/2006/10/07/sarcomatous-pleural-mesothelioma-metastatic-to-left-ventricular-endocardium/#comments</comments>
		<pubDate>Sat, 07 Oct 2006 16:31:35 +0000</pubDate>
		<dc:creator>Administrator</dc:creator>
				<category><![CDATA[Case Study]]></category>
		<category><![CDATA[Full Archive]]></category>
		<category><![CDATA[Pericardial]]></category>
		<category><![CDATA[Pleural]]></category>
		<category><![CDATA[Sarcomatoid]]></category>
		<category><![CDATA[Type of Assessment:]]></category>
		<category><![CDATA[Type of Mesothelioma:]]></category>

		<guid isPermaLink="false">http://www.mesothelioma-line.com/articles/2006/10/07/sarcomatous-pleural-mesothelioma-metastatic-to-left-ventricular-endocardium/</guid>
		<description><![CDATA[Angiology. 2006 Aug-Sep;57(4):517-21. [Link] Senkottaiyan N, Seacord LM, Fulling KH, Birchem JA, Fraley MA, Alpert MA. Department of Medicine and Pathology, St. John&#8217;s Mercy Medical Center, St. Louis, MO 63141, USA. Abstract A 71-year-old man, a cigarette smoker with long-term asbestos exposure, developed multifocal malignant sarcomatous pleural mesothelioma that metastasized to the left ventricular endocardium [...]]]></description>
			<content:encoded><![CDATA[<p><em>Angiology</em>. 2006 Aug-Sep;57(4):517-21. [<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&#038;cmd=Retrieve&#038;dopt=AbstractPlus&#038;list_uids=17022390&#038;itool=iconabstr&#038;itool=pubmed_DocSum" target="_blank">Link</a>]</p>
<p> Senkottaiyan N, Seacord LM, Fulling KH, Birchem JA, Fraley MA, Alpert MA.</p>
<p>Department of Medicine and Pathology, St. John&#8217;s Mercy Medical Center, St. Louis, MO 63141, USA.</p>
<h3 class="abstract">Abstract</h3>
<p>A 71-year-old man, a cigarette smoker with long-term asbestos exposure, developed multifocal malignant sarcomatous pleural mesothelioma that metastasized to the left ventricular endocardium without invading pericardium, myocardium, or the contiguous pulmonary vein. This is the first reported case of malignant pleural mesothelioma to metastasize in such a manner.</p>
<h3 class="glossary">Glossary</h3><dl class="glossary"><dt>mesothelioma</dt><dd>a tumor derived from mesothelial tissue, such as the peritoneum (lining the abdomen) or pleura (lining the lungs). More on <a href="http://www.mesotheliomacenter.org/">mesothelioma</a>. </dd></dl>]]></content:encoded>
			<wfw:commentRss>http://www.mesothelioma-line.com/articles/2006/10/07/sarcomatous-pleural-mesothelioma-metastatic-to-left-ventricular-endocardium/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
